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offer my congratulations to Dr Crawford and his colleagues on
an excellent presentation, a strong manuscript, and for being
considered for the “best trainee paper” award. The group from
Oregon Health Sciences University has presented a retrospective
review of a reasonably contemporary series of patients who pre-
sented to their institution with acute aortic occlusion. While similar
case-series have been published before, this is the ﬁrst to be pre-
sented this century. Perhaps the most notable conclusion is that
despite obvious advances in the care and treatment of the surgical
patient, over the last 35 years, we have been unable to bend the
mortality curve for this acute catastrophe. The overall mortality
of 34% in this paper is similar to the 50% published by my mentors,
Littooy and Baker, in 1986, the 31% published by the group from
Vanderbilt in 1992, 35% from Alex Shepard at Henry Ford in
1994, and 21% from Alan Lumsden when he was at Emory in
1998. This is also despite another consistent ﬁnding, that these
patients, at least by vascular surgery standards, are relatively young.
In fact, they average not much more than 60 years of age in this
and all the prior studies. Part of me wants to conclude that in
a third of patients, the die is cast at the time of the occlusion
and there is nothing the surgeon can do to preserve life; despite
our best efforts, the curve simply cannot be bent. The other part
wants to believe that we can do better with this entity. Maybe
earlier treatment could help. Perhaps some technical adaptation,
like more aggressively approaching the aorta directly, might save
lives. Could more frequent postoperative imaging to assure we
have left no residual clot make a difference?
My questions for Dr Crawford may be more philosophical or
rhetorical than technical, but do the authors have any ideas,
based on their experience, what we might do to effect outcomes?
Or, if they feel that there is nothing that can be done, might
there be a subgroup of patients who could be identiﬁed up front
that should be offered comfort care only? I appreciate the oppor-
tunity to comment on this paper and look forward to your
response.Dr Jeffrey D. Crawford. Dr Morasch, thank you for review-
ing this manuscript and for your insights and questions. You are
correct in that acute aortic occlusion (AAO) continues to be asso-
ciated with signiﬁcant morbidity and mortality. However, we
believe that our series with a postprocedure mortality of 15%,
the lowest observed in any prior review, demonstrates several ﬁnd-
ings that may be pertinent to bending the mortality curve for
AAO. First, we believe extra-anatomic bypass with axillobifemoral
bypass offers a rapid revascularization strategy with less physiologic
strain on the critically ill patient with AAO and with acceptable
patency. Our review also demonstrates that the large majority of
AAOs are now due to in-situ aortic thrombosis rather than embo-
lism more commonly seen in prior decades. This change in the
epidemiology of the disease has implications for potential
improved survival of the AAO patient. Patients with progressive
aortoiliac disease with subsequent acute thrombosis may have
the beneﬁt of developing collaterals which may limit the severity
of tissue ischemia and ultimately affect outcome. In addition, in
the past, embolism may have been associated with acute myocar-
dial infarction, perhaps making recovery more difﬁcult for patients
studied in earlier series.
We do seek to identify patients presenting in severe extremis,
those with prohibitive comorbidities and end-stage malignancies,
as candidates for comfort care measures rather than attempted
revascularization. Early involvement of our colleagues from the
palliative care service can be very helpful in such cases.
We practice surveillance imaging after revascularization. Virtu-
ally all patients with bypass grafts placed for any indication are
examined with duplex ultrasound routinely prior to leaving the
hospital. We have not observed clinically detectable clot progres-
sion postoperatively. Following revascularization for acute aortic
occlusion, our patients are generally continued on anticoagulation
unless there is a contraindication to do so.
Again, we would like to thank Dr Morasch for his comments
and the Western Vascular Surgery for the opportunity to present
our work.
